-
PSG start Ligue 1 defence with eye on Champions League hat-trick
-
Mercedes and Max: What to watch as F1 returns for Dutch GP
-
Arsenal can become world's best club: Arteta
-
'People, not robots': Ukraine's soldiers justify human role amid drone revolution
-
Japan's King Kazu, 59, scores twice from spot to make cup history
-
North Sea drilling tests UK govt climate pledge
-
Kyiv's desperate vendors persevere outside obliterated flea market
-
'Ray of hope': Gaza seed bank rebuilds after wartime destruction
-
Australia races to shield little penguins from H5N1 bird flu
-
Mourinho begins second Real Madrid reign with Barca in his sights
-
Messi scores first goal since father's death
-
'More confrontational': Iran's new hardline security leadership
-
US national debt exceeds $40 trillion for first time
-
UK summons Israeli envoy over West Bank settlement project
-
Brazilian narco violence spills over into tranquil Bolivia
-
Trump vows 'tremendous' economic costs on Iran partners
-
Trump's devoted 'human printer' in media glare
-
Germany, France, UN condemn far-right Israeli minister's 'inhumane' Gaza remarks
-
Top seed Zverev bundled out by Paul in rain-hit Cincinnati upset
-
Prince Harry and Meghan moving back to UK: British press
-
WADA pledges vigilance on Russian athletes ahead of 2028 Olympics
-
Lee, Baena guide Atletico to opening Liga win over Malaga
-
NASA satellite rescue mission fails
-
Ecuador intel chief, five Americans killed in Kenya helicopter crash
-
Cobolli halts Jodar to reach Cincinnati quarter-finals
-
Robinson and Tongue share match ball after dismissing Pakistan
-
As election looms, Netanyahu puts Turkey in Israel's crosshairs
-
Israel army admits firing on car in death of five-year-old Hind Rajab
-
McIlroy questions LIV stars 'value' as talk of PGA return builds
-
Honduras places 80% of country on El Nino drought alert
-
'Breakthrough' mRNA cancer drug curbs melanoma in large trial
-
Some of Meta's safety tools were 'designed to fail': witness
-
Many US Fed policymakers back interest rate hikes if inflation stays high
-
PSG Ligue 1 opener moved over state of Parc des Princes pitch
-
Robinson and Tongue star as Pakistan collapse in England opener
-
UK PM launches bid to help homeless, donating part of his wages
-
All Blacks must get 'everything right' to beat Springboks, says legend Fitzpatrick
-
Golden Shoe winner Kane hopes for Ballon d'Or after 'best season ever'
-
Robinson and Tongue star as Pakistan all out for 171 in England opener
-
Kyiv's ex-defence chief makes risky bet by venturing into electoral grounds
-
Lake Zurich sees water level hit record low amid drought
-
Coventry have survival inspiration says Lampard
-
Merck and Moderna's tailored cancer drug curbs melanoma recurrence in trial
-
Reijnders leaves Man City for Saudi's Al Qadsiah
-
Referees chief Webb wants clamp-down on Premier League set-piece grappling
-
Trump says will meet North Korea's Kim later this year
-
Robinson makes history as Pakistan collapse against England
-
Stocks waver, dollar drops as US Treasury moves to lower bond yields
-
Alvarez can win back Atletico fans in two games: club chief
-
France recalls rare disease drug Tavneos after deaths
Formerra to Supply Foster Medical Compounds in Europe
Expanded agreement infuses Formerra's European healthcare polymer portfolio with life-saving Foster® compounds.
PUTNAM, CT AND ROMEOVILLE, IL / ACCESS Newswire / January 29, 2026 / Formerra and GEON® Performance Solutions today announced an agreement that designates Formerra as the preferred distributor of Foster®, LLC medical compounds in Europe. This adds to Formerra's current distribution of these materials in North and South America, enabling Formerra to now support customers who need the same product in all regions.
Following GEON's January 2025 acquisition of Foster, the agreement builds on Formerra's long-standing, global partnership with GEON for flexible and rigid PVC and filled polypropylene materials.

"Bringing Foster's medical-grade portfolio to Europe strengthens our ability to support healthcare manufacturers across the region with specialized compounds and the local expertise they need to navigate complex regulatory environments," said Kelly Wessner, Vice President, Key Accounts, Formerra. "Building on the momentum of our Americas partnership, we're excited to extend these proven solutions to European customers who demand the highest standards in medical device materials."
With more than 30 years in custom medical polymer compounding, Foster delivers highly engineered, top-of-the-polymer-pyramid formulations tailored to demanding requirements. The portfolio includes options such as radiopaque compounds and grades that meet USP Class VI requirements and align with ISO 10993 expectations. These materials support critical end uses across the healthcare space, including implantable products and other highly specialized applications.
"Extending our Foster portfolio into Europe with Formerra allows us to meet growing demand from healthcare manufacturers in one of the world's most dynamic medical device markets," said Arthur Adams, Chief Commercial Officer, GEON. "This expansion reinforces our shared commitment to supporting innovation in life-saving applications globally."
Adding Foster® compounds to its European portfolio will enable Formerra to better serve customers in the healthcare space, offering not only access to highly engineered medical polymers, but also deep regulatory expertise and responsive logistics across the region.
Formerra will exhibit at MD&M West in Booth 2266 in Anaheim, California, February 3-5, 2026.
###
Key Details
Formerra will distribute Foster® medical compounds in Europe.
This agreement adds custom medical-grade compounds to Formerra's existing global access to GEON® PVC and filled PP materials.
About Formerra
Formerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.
About GEON Performance Solutions
GEON® Performance Solutions unlocks the power of polymers for the future. From biomedical materials from our medical division, Foster, LLC, to building materials, automotive, connectivity, and appliances, customers in these markets rely on the portfolio of compounding solutions, highly adaptable vinyl, polyolefin, engineered resin technologies, and full-service contract manufacturing that we deliver. In every formulation, collaboration, and challenge we're shaping the brilliance of tomorrow and providing a formidable advantage by engineering what's possible. Geon has approximately 1,200 global associates and 15 world-class manufacturing plants with headquarters in Westlake, Ohio. Learn more at www.geon.com. Geon is a portfolio company of SK Capital Partners.
Media Contact
Jackie Morris
Marketing Communications Manager, Formerra
[email protected]
+1 630-972-3144
SOURCE: Formerra
View the original press release on ACCESS Newswire
X.Habash--SF-PST